177 related articles for article (PubMed ID: 35158462)
1. Molecular characterization of the gut microbiome in egyptian patients with remitting relapsing multiple sclerosis.
Mekky J; Wani R; Said SM; Ashry M; Ibrahim AE; Ahmed SM
Mult Scler Relat Disord; 2022 Jan; 57():103354. PubMed ID: 35158462
[TBL] [Abstract][Full Text] [Related]
2. Study of the gut microbiome in Egyptian patients with Parkinson's Disease.
Mehanna M; AbuRaya S; Ahmed SM; Ashmawy G; Ibrahim A; AbdelKhaliq E
BMC Microbiol; 2023 Jul; 23(1):196. PubMed ID: 37481569
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota as a Potential Predictive Biomarker in Relapsing-Remitting Multiple Sclerosis.
Navarro-López V; Méndez-Miralles MÁ; Vela-Yebra R; Fríes-Ramos A; Sánchez-Pellicer P; Ruzafa-Costas B; Núñez-Delegido E; Gómez-Gómez H; Chumillas-Lidón S; Picó-Monllor JA; Navarro-Moratalla L
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627315
[TBL] [Abstract][Full Text] [Related]
4. Genetic risk score in multiple sclerosis is associated with unique gut microbiome.
Elsayed NS; Valenzuela RK; Kitchner T; Le T; Mayer J; Tang ZZ; Bayanagari VR; Lu Q; Aston P; Anantharaman K; Shukla SK
Sci Rep; 2023 Sep; 13(1):16269. PubMed ID: 37758833
[TBL] [Abstract][Full Text] [Related]
5. Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis.
Pellizoni FP; Leite AZ; Rodrigues NC; Ubaiz MJ; Gonzaga MI; Takaoka NNC; Mariano VS; Omori WP; Pinheiro DG; Matheucci Junior E; Gomes E; de Oliveira GLV
Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925359
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.
Chen J; Chia N; Kalari KR; Yao JZ; Novotna M; Paz Soldan MM; Luckey DH; Marietta EV; Jeraldo PR; Chen X; Weinshenker BG; Rodriguez M; Kantarci OH; Nelson H; Murray JA; Mangalam AK
Sci Rep; 2016 Jun; 6():28484. PubMed ID: 27346372
[TBL] [Abstract][Full Text] [Related]
7. Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis.
Zeng Q; Junli Gong ; Liu X; Chen C; Sun X; Li H; Zhou Y; Cui C; Wang Y; Yang Y; Wu A; Shu Y; Hu X; Lu Z; Zheng SG; Qiu W; Lu Y
Neurochem Int; 2019 Oct; 129():104468. PubMed ID: 31108132
[TBL] [Abstract][Full Text] [Related]
8. Study of gut microbiome in Egyptian patients with autoimmune thyroid diseases.
El-Zawawy HT; Ahmed SM; El-Attar EA; Ahmed AA; Roshdy YS; Header DA
Int J Clin Pract; 2021 May; 75(5):e14038. PubMed ID: 33482041
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota in forty cases of egyptian relapsing remitting multiple sclerosis.
Elgendy SG; Abd-Elhameed R; Daef E; Mohammed SM; Hassan HM; El-Mokhtar MA; Nasreldein A; Khedr EM
Iran J Microbiol; 2021 Oct; 13(5):632-641. PubMed ID: 34900161
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes.
Reynders T; Devolder L; Valles-Colomer M; Van Remoortel A; Joossens M; De Keyser J; Nagels G; D'hooghe M; Raes J
Ann Clin Transl Neurol; 2020 Apr; 7(4):406-419. PubMed ID: 32162850
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
Yadav M; Ali S; Shrode RL; Shahi SK; Jensen SN; Hoang J; Cassidy S; Olalde H; Guseva N; Paullus M; Cherwin C; Wang K; Cho T; Kamholz J; Mangalam AK
PLoS One; 2022; 17(4):e0264556. PubMed ID: 35472144
[TBL] [Abstract][Full Text] [Related]
12. Study of the gut microbiome in Egyptian patients with type 1 diabetes mellitus.
Allakany AI; Elbanna AA; Rohoma KH; Ahmed SM; Ibrahim AE; Fawzy MA; Header DA
Prz Gastroenterol; 2023; 18(2):190-197. PubMed ID: 37538290
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
Shahi SK; Freedman SN; Mangalam AK
Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis.
Takewaki D; Suda W; Sato W; Takayasu L; Kumar N; Kimura K; Kaga N; Mizuno T; Miyake S; Hattori M; Yamamura T
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22402-22412. PubMed ID: 32839304
[TBL] [Abstract][Full Text] [Related]
15. Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis.
Sterlin D; Larsen M; Fadlallah J; Parizot C; Vignes M; Autaa G; Dorgham K; Juste C; Lepage P; Aboab J; Vicart S; Maillart E; Gout O; Lubetzki C; Deschamps R; Papeix C; Gorochov G
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 33975914
[TBL] [Abstract][Full Text] [Related]
16. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.
Miyake S; Kim S; Suda W; Oshima K; Nakamura M; Matsuoka T; Chihara N; Tomita A; Sato W; Kim SW; Morita H; Hattori M; Yamamura T
PLoS One; 2015; 10(9):e0137429. PubMed ID: 26367776
[TBL] [Abstract][Full Text] [Related]
17. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the human gut microbiome in multiple sclerosis.
Jangi S; Gandhi R; Cox LM; Li N; von Glehn F; Yan R; Patel B; Mazzola MA; Liu S; Glanz BL; Cook S; Tankou S; Stuart F; Melo K; Nejad P; Smith K; Topçuolu BD; Holden J; Kivisäkk P; Chitnis T; De Jager PL; Quintana FJ; Gerber GK; Bry L; Weiner HL
Nat Commun; 2016 Jun; 7():12015. PubMed ID: 27352007
[TBL] [Abstract][Full Text] [Related]
19. Study of the gut Microbiome Profile in Children with Autism Spectrum Disorder: a Single Tertiary Hospital Experience.
Ahmed SA; Elhefnawy AM; Azouz HG; Roshdy YS; Ashry MH; Ibrahim AE; Meheissen MA
J Mol Neurosci; 2020 Jun; 70(6):887-896. PubMed ID: 32062762
[TBL] [Abstract][Full Text] [Related]
20. Role of the gut microbiome in multiple sclerosis: From etiology to therapeutics.
Shahi SK; Yadav M; Ghimire S; Mangalam AK
Int Rev Neurobiol; 2022; 167():185-215. PubMed ID: 36427955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
